Literature DB >> 23640510

Large-area versus small-area application of mitomycin C during trabeculectomy.

Juliane Matlach1, Ermioni Panidou, Franz Grehn, Thomas Klink.   

Abstract

PURPOSE: To compare 2 different application methods of mitomycin C (MMC) in patients undergoing trabeculectomy.
METHODS: This retrospective trial compared outcomes of 191 eyes that underwent trabeculectomy with small-area (96 eyes; 50.3%) and large-area (95 eyes; 49.7%) MMC application. Main outcome measures were changes in intraocular pressure (IOP), required glaucoma medications, the frequency of complications, and postsurgical interventions.
RESULTS: Within both treatment groups, a highly significant IOP reduction was seen during follow-up (p < 0.0001). Statistical analyses revealed a significant difference in IOP between both groups. Patients treated with a larger size of surface area had a higher IOP reduction within the first postoperative year. Choroidal detachment, shallow anterior chamber, and bleb leak were seen more often in the large-area group with more aggressive MMC use. In contrast, complications associated with bleb failure such as bleb scarring were higher in the small-area group. Success rate was higher in the large-area MMC application group after 12 months.
CONCLUSIONS: Large-area treatment seems to be a more efficient application method of MMC during trabeculectomy.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23640510     DOI: 10.5301/ejo.5000287

Source DB:  PubMed          Journal:  Eur J Ophthalmol        ISSN: 1120-6721            Impact factor:   2.597


  13 in total

1.  [Intraoperative inhibition of fibrosis in modern trabeculectomy].

Authors:  A Koutsonas; A Remky; N Plange
Journal:  Ophthalmologe       Date:  2013-07       Impact factor: 1.059

2.  A comparative study of sutureless scleral tunnel trabeculectomy versus conventional trabeculectomy in the management of primary open-angle glaucoma.

Authors:  Mohammad Arish; Hoda Khallaghi; Elham Soltani; Reza Akbarpour
Journal:  Int Ophthalmol       Date:  2014-02-04       Impact factor: 2.031

3.  Clinical outcomes of amniotic membrane loaded with 5-FU PLGA nanoparticles in experimental trabeculectomy.

Authors:  Fang Hu; Xiang-Yun Zeng; Zhao-Lian Xie; Lin-Lin Liu; Liang Huang
Journal:  Int J Ophthalmol       Date:  2015-02-18       Impact factor: 1.779

4.  Biodegradable PTLGA Terpolymers versus Collagen Implants Used as an Adjuvant in Trabeculectomy in Rabbit Eye.

Authors:  Weiran Niu; Guanglin Shen; Yuanzhi Yuan; Xiaoping Ma; Suming Li; Jingzhao Wang; Zhongyong Fan; Lan Liao
Journal:  J Ophthalmol       Date:  2015-11-30       Impact factor: 1.909

5.  A comparative study of a modified filtering trabeculotomy and conventional trabeculectomy.

Authors:  Juliane Matlach; Matthias Hipp; Martin Wagner; Peter U Heuschmann; Thomas Klink; Franz Grehn
Journal:  Clin Ophthalmol       Date:  2015-03-13

6.  Current and Future Techniques in Wound Healing Modulation after Glaucoma Filtering Surgeries.

Authors:  Masoumeh B Masoumpour; M Hossein Nowroozzadeh; M Reza Razeghinejad
Journal:  Open Ophthalmol J       Date:  2016-02-29

7.  Long-Term Outcomes of Primary Trabeculectomy in Diabetic Patients without Retinopathy with Primary Angle-Closure Glaucoma.

Authors:  Jian Liu; Miaomiao Zhang; Bin Li; Jianrong Wang
Journal:  J Ophthalmol       Date:  2017-02-26       Impact factor: 1.909

Review 8.  Improving patient outcomes following glaucoma surgery: state of the art and future perspectives.

Authors:  Tine Van Bergen; Sarah Van de Velde; Evelien Vandewalle; Lieve Moons; Ingeborg Stalmans
Journal:  Clin Ophthalmol       Date:  2014-05-02

9.  Ranibizumab Plus Combined Surgery for Treatment of Neovascular Glaucoma with Vitreous Hemorrhage.

Authors:  Xiu-Juan Li; Xiao-Peng Yang; Qiu-Ming Li; Yu-Ying Wang; Xiao-Bei Lyu
Journal:  Chin Med J (Engl)       Date:  2015-08-05       Impact factor: 2.628

Review 10.  A review of the efficacy of mitomycin C in glaucoma filtration surgery.

Authors:  Ahmed Al Habash; Leyla Ali Aljasim; Ohoud Owaidhah; Deepak P Edward
Journal:  Clin Ophthalmol       Date:  2015-10-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.